|
Q |
Cardf1 |
Cardiac cell morphology QTL 1 |
|
IDA |
|
RGD |
PMID:14532335 |
RGD:727992 |
NCBI chr13:11,929,449...45,417,941
|
|
Q |
Eutr1 |
Estrogen induced uterine response QTL 1 |
|
IDA |
|
RGD |
PMID:16284801 |
RGD:1559292 |
NCBI chr 5:2,138,965...166,875,058
|
|
Q |
Eutr2 |
Estrogen induced uterine response QTL 2 |
|
IDA |
|
RGD |
PMID:16284802 |
RGD:1559291 |
NCBI chr 5:34,730,116...104,251,008
|
|
Q |
Gcr1 |
Gastric cancer resistance QTL 1 |
|
IDA |
|
RGD |
PMID:10706129 |
RGD:69698 |
NCBI chr 4:120,260,281...147,278,687
|
|
Q |
Gcr2 |
Gastric cancer resistance QTL 2 |
|
IDA |
|
RGD |
PMID:10706129 |
RGD:69698 |
NCBI chr 3:8,658,162...27,494,778
|
|
Q |
Gcs1 |
Gastric cancer susceptibility QTL1 |
|
IDA |
|
RGD |
PMID:10706129 |
RGD:69698 |
NCBI chr15:76,306,099...101,769,107
|
|
Q |
Ginf1 |
Gastrointestinal inflammation QTL 1 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr 8:4,705,810...49,705,810
|
|
Q |
Ginf2 |
Gastrointestinal inflammation QTL 2 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr 8:4,705,810...49,705,810
|
|
Q |
Ginf3 |
Gastrointestinal inflammation QTL 3 |
|
IDA |
|
RGD |
PMID:19526527 |
RGD:2316974 |
NCBI chr17:49,920,154...86,533,673
|
|
Q |
Mamtr2 |
Mammary tumor resistance QTL 2 |
|
IDA |
|
RGD |
PMID:14522903 |
RGD:724790 |
NCBI chr 2:7,887,772...12,654,247
|
|
Q |
Mamtr3 |
Mammary tumor resistance QTL 3 |
|
IDA |
|
RGD |
PMID:14522903 |
RGD:724790 |
NCBI chr 2:32,373,770...43,665,178
|
|
Q |
Mamtr4 |
Mammary tumor resistance QTL 4 |
|
IDA |
|
RGD |
PMID:14522903 |
RGD:724790 |
NCBI chr 2:16,491,740...61,491,740
|
|
Q |
Renag1 |
Renal agenesis QTL 1 |
|
IDA |
|
RGD |
PMID:16845468 |
RGD:1580355 |
NCBI chr14:8,170,668...68,298,175
|
|
Q |
Schws8 |
Schwannoma susceptibility QTL 8 |
|
IDA |
|
RGD |
PMID:25303613 |
RGD:11566050 |
NCBI chr 6:94,968,928...139,968,928
|
|
Q |
Schws9 |
Schwannoma susceptibility QTL 9 |
|
IDA |
|
RGD |
PMID:25303613 |
RGD:11566050 |
NCBI chr 6:61,747,639...106,747,639
|
|
Q |
Tcas11 |
Tongue tumor susceptibility QTL 11 |
|
IDA |
|
RGD |
PMID:16527513 |
RGD:1578522 |
NCBI chr 5:46,711,509...161,317,411
|
|
Q |
Tcas7 |
Tongue tumor susceptibility QTL 7 |
|
IDA |
|
RGD |
PMID:15876484 |
RGD:1358147 |
NCBI chr19:24,817,978...39,654,489
|
|
Q |
Tls1 |
T-lymphoma susceptibility QTL 1 |
|
IDA |
|
RGD |
PMID:10360666 |
RGD:619600 |
NCBI chr 5:90,450,144...135,450,144
|
|
Q |
Tls2 |
T-lymphoma susceptibility QTL 2 |
|
IDA |
|
RGD |
PMID:10360666 |
RGD:619600 |
NCBI chr 7:80,221,299...109,401,111
|
|
Q |
Tls3 |
T-lymphoma susceptibility QTL 3 |
|
IDA |
|
RGD |
PMID:10360666 |
RGD:619600 |
NCBI chr10:51,774,612...95,600,334
|
|
Q |
Vetf1 |
Vascular elastic tissue fragility QTL 1 |
|
IDA |
|
RGD |
PMID:11526202 |
RGD:619605 |
NCBI chr 5:2,282,226...5,904,428
|
|
Q |
Vetf2 |
Vascular elastic tissue fragility QTL 2 |
|
IDA |
|
RGD |
PMID:11526202 |
RGD:619605 |
NCBI chr10:41,142,633...86,142,633
|
|